Overview

68Ga-FAPI PET/MR for Atherosclerosis

Status:
Recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
A thin-cap fibroatheroma with a large necrotic core and macrophage infiltration marks the vulnerable plaque. Fibroblast activating protein (FAP) is an active serine protease, which can degrade type I collagen, potentially thinning the fibrous cap. Thus we speculate that atherosclerotic plaque could be imaged with 68Ga-FAPI PET/MR.
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital